BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 35119630)

  • 1. Diabetes-Associated Mutations in Proinsulin Provide a "Molecular Rheostat" of Nascent Foldability.
    Dhayalan B; Weiss MA
    Curr Diab Rep; 2022 Feb; 22(2):85-94. PubMed ID: 35119630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural Lessons From the Mutant Proinsulin Syndrome.
    Dhayalan B; Chatterjee D; Chen YS; Weiss MA
    Front Endocrinol (Lausanne); 2021; 12():754693. PubMed ID: 34659132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide Model of the Mutant Proinsulin Syndrome. I. Design and Clinical Correlation.
    Dhayalan B; Glidden MD; Zaykov AN; Chen YS; Yang Y; Phillips NB; Ismail-Beigi F; Jarosinski MA; DiMarchi RD; Weiss MA
    Front Endocrinol (Lausanne); 2022; 13():821069. PubMed ID: 35299972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proinsulin misfolding and endoplasmic reticulum stress during the development and progression of diabetes.
    Sun J; Cui J; He Q; Chen Z; Arvan P; Liu M
    Mol Aspects Med; 2015 Apr; 42():105-18. PubMed ID: 25579745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoplasmic reticulum oxidoreductin-1α (Ero1α) improves folding and secretion of mutant proinsulin and limits mutant proinsulin-induced endoplasmic reticulum stress.
    Wright J; Birk J; Haataja L; Liu M; Ramming T; Weiss MA; Appenzeller-Herzog C; Arvan P
    J Biol Chem; 2013 Oct; 288(43):31010-8. PubMed ID: 24022479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct states of proinsulin misfolding in MIDY.
    Haataja L; Arunagiri A; Hassan A; Regan K; Tsai B; Dhayalan B; Weiss MA; Liu M; Arvan P
    Cell Mol Life Sci; 2021 Aug; 78(16):6017-6031. PubMed ID: 34245311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biosynthesis, structure, and folding of the insulin precursor protein.
    Liu M; Weiss MA; Arunagiri A; Yong J; Rege N; Sun J; Haataja L; Kaufman RJ; Arvan P
    Diabetes Obes Metab; 2018 Sep; 20 Suppl 2(Suppl 2):28-50. PubMed ID: 30230185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological behaviors of mutant proinsulin contribute to the phenotypic spectrum of diabetes associated with insulin gene mutations.
    Wang H; Saint-Martin C; Xu J; Ding L; Wang R; Feng W; Liu M; Shu H; Fan Z; Haataja L; Arvan P; Bellanné-Chantelot C; Cui J; Huang Y
    Mol Cell Endocrinol; 2020 Dec; 518():111025. PubMed ID: 32916194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptide Model of the Mutant Proinsulin Syndrome. II. Nascent Structure and Biological Implications.
    Yang Y; Glidden MD; Dhayalan B; Zaykov AN; Chen YS; Wickramasinghe NP; DiMarchi RD; Weiss MA
    Front Endocrinol (Lausanne); 2022; 13():821091. PubMed ID: 35299958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes mellitus due to the toxic misfolding of proinsulin variants.
    Weiss MA
    FEBS Lett; 2013 Jun; 587(13):1942-50. PubMed ID: 23669362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes mellitus due to toxic misfolding of proinsulin variants.
    Dhayalan B; Chatterjee D; Chen YS; Weiss MA
    Mol Metab; 2021 Apr; ():101229. PubMed ID: 33823319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutant INS-gene induced diabetes of youth: proinsulin cysteine residues impose dominant-negative inhibition on wild-type proinsulin transport.
    Liu M; Haataja L; Wright J; Wickramasinghe NP; Hua QX; Phillips NF; Barbetti F; Weiss MA; Arvan P
    PLoS One; 2010 Oct; 5(10):e13333. PubMed ID: 20948967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Misfolded proinsulin in the endoplasmic reticulum during development of beta cell failure in diabetes.
    Arunagiri A; Haataja L; Cunningham CN; Shrestha N; Tsai B; Qi L; Liu M; Arvan P
    Ann N Y Acad Sci; 2018 Apr; 1418(1):5-19. PubMed ID: 29377149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disulfide Mispairing During Proinsulin Folding in the Endoplasmic Reticulum.
    Haataja L; Manickam N; Soliman A; Tsai B; Liu M; Arvan P
    Diabetes; 2016 Apr; 65(4):1050-60. PubMed ID: 26822090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proinsulin misfolding and diabetes: mutant INS gene-induced diabetes of youth.
    Liu M; Hodish I; Haataja L; Lara-Lemus R; Rajpal G; Wright J; Arvan P
    Trends Endocrinol Metab; 2010 Nov; 21(11):652-9. PubMed ID: 20724178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of insulin at the edge of foldability and its medical implications.
    Rege NK; Liu M; Yang Y; Dhayalan B; Wickramasinghe NP; Chen YS; Rahimi L; Guo H; Haataja L; Sun J; Ismail-Beigi F; Phillips NB; Arvan P; Weiss MA
    Proc Natl Acad Sci U S A; 2020 Nov; 117(47):29618-29628. PubMed ID: 33154160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. INS-gene mutations: from genetics and beta cell biology to clinical disease.
    Liu M; Sun J; Cui J; Chen W; Guo H; Barbetti F; Arvan P
    Mol Aspects Med; 2015 Apr; 42():3-18. PubMed ID: 25542748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proinsulin and the genetics of diabetes mellitus.
    Weiss MA
    J Biol Chem; 2009 Jul; 284(29):19159-63. PubMed ID: 19395706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chaperone-Driven Degradation of a Misfolded Proinsulin Mutant in Parallel With Restoration of Wild-Type Insulin Secretion.
    Cunningham CN; He K; Arunagiri A; Paton AW; Paton JC; Arvan P; Tsai B
    Diabetes; 2017 Mar; 66(3):741-753. PubMed ID: 28028074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired cleavage of preproinsulin signal peptide linked to autosomal-dominant diabetes.
    Liu M; Lara-Lemus R; Shan SO; Wright J; Haataja L; Barbetti F; Guo H; Larkin D; Arvan P
    Diabetes; 2012 Apr; 61(4):828-37. PubMed ID: 22357960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.